Crosstalk between cell fate and survival pathways during uterine cervical carcinoma progression: a molecular and clinical perspective
Authors:
- 16 August 2023
- journal article
- review article
- Published by OAE Publishing Inc. in Journal of Cancer Metastasis and Treatment
- Vol. 9
Abstract
The development of uterine cervical cancer is primarily attributed to infection by high-risk human papillomaviruses (HR-HPVs). E5, E6 and E7, the three early oncoproteins of HR-HPVs, have been implicated in initiation and progression of cervical cancer. The intricate molecular mechanisms that orchestrate aberrant cellular transformations to establish carcinoma of the cervical epithelium following viral infections are poorly understood. Here, we discuss how deregulation of three major cell fate regulatory pathways, Hedgehog, Wnt and Notch, and cell survival strategies involving EGFR signaling and G1/S checkpoint contribute towards cervical cancer development and progression. Further exploration of protein interaction database has revealed several genes that are involved in cervical cancer initiation and progression, and the two crucial "driver” genes, MYC and CTNNB1 (β-catenin), have been identified as major players in protein-protein interaction network. GSK3β emerged as the key mediator of crosstalk between Hedgehog, Wnt and Notch signaling pathways. GSK3β regulates cytoplasmic stabilization and nuclear translocation of β-catenin, which further impacts the expression of MYC, critical for cell cycle progression. Collectively, our analyses suggest that combinatorial therapeutic targeting of these proteins may be more effective in blocking cervical cancer initiation and progression.Keywords
This publication has 122 references indexed in Scilit:
- Mitotic and mitogenic Wnt signallingThe EMBO Journal, 2012
- The many faces and functions of β‐cateninThe EMBO Journal, 2012
- Non-canonical Notch signaling: emerging role and mechanismTrends in Cell Biology, 2012
- Preventable Exposures Associated With Human CancersJNCI: Journal of the National Cancer Institute, 2011
- EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic targetBritish Journal of Cancer, 2011
- Notch1 regulates the functional contribution of RhoC to cervical carcinoma progressionBritish Journal of Cancer, 2009
- Finding One's Niche in the SkinCell Stem Cell, 2009
- Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in miceProceedings of the National Academy of Sciences, 2006
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- The Hallmarks of CancerCell, 2000